Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-02

Clinical Trial Update: Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypofractionated whole-breast irradiation with a simultaneously integrated boost after breast-conserving surgery for early-stage breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN